Results
1 -
9 of
9
(Click
here to explore results)
- Macrocycles in Drug Discovery, CHAPTER 7 Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets. Wieslaw M. Kazmierski, Richard L. Jarvest, Jacob J. Plattner, Xianfeng Li
, 2015
, Pages 235-282
- Macrocycles in Drug Discovery, Subject Index
, 2015
, Pages 487-499
- Macrocycles in Drug Discovery, Contents
, 2015
, Pages P013-P020
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 8 Design and Development of NS5B Polymerase Non‐nucleoside Inhibitors for the Treatment of Hepatitis C Virus Infection. Pierre L. Beaulieu
, 2013
, Pages 248-294
- Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 7 HCV NS3/4a Protease Inhibitors: Simeprevir (TMC‐435350), Vaniprevir (MK‐7009) and MK‐5172. John A. McCauley, Michael T. Rudd, Nigel J. Liverton
, 2013
, Pages 189-247
- The Medicinal Chemist's Guide to Solving ADMET Challenges, Subject Index
, 2021
, Pages 493-517
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- The Medicinal Chemist's Guide to Solving ADMET Challenges, CHAPTER 7 OATPs: The SLCO Family of Organic Anion Transporting Polypeptide Transporters. Maria Karlgren, Pär Matsson
, 2021
, Pages 143-159